158 related articles for article (PubMed ID: 36794163)
1. Natural Killer Cell Activity Test Helps to Suspect Aggressive Natural Killer Cell Leukemia - Diagnostic Challenge.
You E; Park CJ; Lee MY; Cho YU; Jang S; Lee JH; Lee JH; Lee KH
Int J Med Sci; 2023; 20(2):206-210. PubMed ID: 36794163
[TBL] [Abstract][Full Text] [Related]
2. A probable identical Epstein-Barr virus clone-positive composite lymphoma with aggressive natural killer-cell leukemia and cytotoxic T-cell lymphoma.
Sugimoto KJ; Shimada A; Wakabayashi M; Imai H; Sekiguchi Y; Nakamura N; Sawada T; Ota Y; Takeuchi K; Ito Y; Kimura H; Komatsu N; Noguchi M
Int J Clin Exp Pathol; 2014; 7(1):411-7. PubMed ID: 24427365
[TBL] [Abstract][Full Text] [Related]
3. Aggressive natural killer cell leukemia or extranodal NK/T cell lymphoma? a case with nasal involvement.
Jin X; Xu Y; Zhang J; Li G; Huang D; Yang Y; He H
Diagn Pathol; 2017 Jun; 12(1):46. PubMed ID: 28623913
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel CCDC22 mutation in a patient with severe Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis and aggressive natural killer cell leukemia.
Yamashita Y; Nishikawa A; Iwahashi Y; Fujimoto M; Sasaki I; Mishima H; Kinoshita A; Hemmi H; Kanazawa N; Ohshima K; Imadome KI; Murata SI; Yoshiura KI; Kaisho T; Sonoki T; Tamura S
Int J Hematol; 2019 Jun; 109(6):744-750. PubMed ID: 30706328
[TBL] [Abstract][Full Text] [Related]
5. Possible Concomitant Aggressive NK Cell Leukemia and EBV-positive T-cell lymphoma; Using the online beta version of WHO-HAEM5 and videoconferencing software to make diagnoses accessible in an emerging economy.
Dayton VJ; Hoang Thien D; Xinh PT; Arries C; Sang NN; Linh NNN; Lien NP; Dung PC
Diagn Pathol; 2023 Oct; 18(1):111. PubMed ID: 37803436
[TBL] [Abstract][Full Text] [Related]
6. Flow Cytometric Immunophenotyping Is Sensitive for the Early Diagnosis of De Novo Aggressive Natural Killer Cell Leukemia (ANKL): A Multicenter Retrospective Analysis.
Li Y; Wei J; Mao X; Gao Q; Liu L; Cheng P; Liu L; Zhang X; Zhang K; Wang J; Zhu L; Zhou J; Zhang Y; Meng L; Sun H; Li D; Huang M; Huang W; Deng J; Zhang D
PLoS One; 2016; 11(8):e0158827. PubMed ID: 27483437
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
Hue SS; Oon ML; Wang S; Tan SY; Ng SB
Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131
[TBL] [Abstract][Full Text] [Related]
8. EBV-negative Aggressive NK-cell Leukemia/Lymphoma: Clinical, Pathologic, and Genetic Features.
Nicolae A; Ganapathi KA; Pham TH; Xi L; Torres-Cabala CA; Nanaji NM; Zha HD; Fan Z; Irwin S; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2017 Jan; 41(1):67-74. PubMed ID: 27631517
[TBL] [Abstract][Full Text] [Related]
9. The superiority of Epstein-Barr virus DNA in plasma over in peripheral blood mononuclear cells for monitoring EBV-positive NK-cell lymphoproliferative diseases.
Zheng M; Bao Y; Wang J; Ma Y; Yang Y; Zhang P; Chen L; Zheng K; Zhou J
Hematol Oncol; 2022 Aug; 40(3):381-389. PubMed ID: 35405763
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cell malignancy associated with Epstein-Barr virus and hemophagocytic syndrome.
Warnnissorn N; Kanitsap N; Kulkantrakorn K; Assanasen T
J Med Assoc Thai; 2007 May; 90(5):982-7. PubMed ID: 17596056
[TBL] [Abstract][Full Text] [Related]
12. Aggressive natural killer cell leukemia with skin manifestation associated with hemophagocytic lymphohistiocytosis: A case report.
Peng XH; Zhang LS; Li LJ; Guo XJ; Liu Y
World J Clin Cases; 2021 Dec; 9(34):10708-10714. PubMed ID: 35005005
[TBL] [Abstract][Full Text] [Related]
13. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.
Chan JK; Sin VC; Wong KF; Ng CS; Tsang WY; Chan CH; Cheung MM; Lau WH
Blood; 1997 Jun; 89(12):4501-13. PubMed ID: 9192774
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
[TBL] [Abstract][Full Text] [Related]
15. Aggressive natural killer cell leukemia: is Epstein-Barr virus negativity an indicator of a favorable prognosis?
Ko YH; Park S; Kim K; Kim SJ; Kim WS
Acta Haematol; 2008; 120(4):199-206. PubMed ID: 19153474
[TBL] [Abstract][Full Text] [Related]
16. Favorable outcome in a child with EBV-negative aggressive NK cell leukemia.
Park JA; Jun KR; Nam SH; Ghim TT
Int J Hematol; 2013 May; 97(5):673-6. PubMed ID: 23550023
[TBL] [Abstract][Full Text] [Related]
17. Frequent CD7 antigen loss in aggressive natural killer-cell leukemia: a useful diagnostic marker.
Yoo EH; Kim HJ; Lee ST; Kim WS; Kim SH
Korean J Lab Med; 2009 Dec; 29(6):491-6. PubMed ID: 20046078
[TBL] [Abstract][Full Text] [Related]
18. EBV-negative aggressive NK-cell leukemia/lymphoma: a clinical and pathological study from a single institution.
Gao J; Behdad A; Ji P; Wolniak KL; Frankfurt O; Chen YH
Mod Pathol; 2017 Aug; 30(8):1100-1115. PubMed ID: 28548121
[TBL] [Abstract][Full Text] [Related]
19. Monomorphic agranular natural killer cell lymphoma/leukemia with no Epstein-Barr virus association.
Matano S; Nakamura S; Nakamura S; Annen Y; Hattori N; Kobayashi K; Kyoda K; Sugimoto T
Acta Haematol; 1999; 101(4):206-8. PubMed ID: 10436303
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and Pathological Characteristics of Aggressive Natural Killer Cell Leukemia Patients].
Wang LP; Yu YP; Mei JG; Song P; An ZM; Zhou XG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1093-1100. PubMed ID: 34362487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]